New Developments in Myeloma Treatment and Response Assessment

© 2023 by the Society of Nuclear Medicine and Molecular Imaging. Immediate Open Access: Creative Commons Attribution 4.0 International License (CC BY) allows users to share and adapt with attribution, excluding materials credited to previous publications. License: https://creativecommons.org/licenses/by/4.0/. Details: http://jnm.snmjournals.org/site/misc/permission.xhtml

Author Information

¹Médecine nucléaire, CHU Nantes, Nantes Université, Université Angers, INSERM, CNRS, CRCI2NA, F-44000, Nantes, France;
²Médecine nucléaire, CHU Nantes, F-44000, Nantes, France;
³Department of Nuclear Medicine, Alma Mater Studiorum, University of Bologna, Bologna. Italy;
⁴IRCCS Azienda Ospedaliero–Universitaria di Bologna, Istituto di Ematologia “Seràgnoli,” Bologna, Italy;
⁵Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy;
⁶Hématologie, CHU Nantes, Nantes Université, Université Angers, INSERM, CNRS, CRCI2NA, F-44000, Nantes, France; and
⁷Nuclear Medicine, IRCCS Azienda Ospedaliero–Universitaria di Bologna, Bologna, Italy

For correspondence or reprints, contact Cristina Nanni (cristina.nanni{at}aosp.bo.it).